Your browser doesn't support javascript.
loading
IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity.
Cunha, Cristina; Gonçalves, Samuel M; Duarte-Oliveira, Cláudio; Leite, Luís; Lagrou, Katrien; Marques, António; Lupiañez, Carmen B; Mesquita, Inês; Gaifem, Joana; Barbosa, Ana Margarida; Pinho Vaz, Carlos; Branca, Rosa; Campilho, Fernando; Freitas, Fátima; Ligeiro, Dário; Lass-Flörl, Cornelia; Löffler, Jürgen; Jurado, Manuel; Saraiva, Margarida; Kurzai, Oliver; Rodrigues, Fernando; Castro, António G; Silvestre, Ricardo; Sainz, Juan; Maertens, Johan A; Torrado, Egídio; Jacobsen, Ilse D; Lacerda, João F; Campos, António; Carvalho, Agostinho.
Afiliación
  • Cunha C; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Gonçalves SM; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Duarte-Oliveira C; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Leite L; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto, Porto, Portugal.
  • Lagrou K; Department of Microbiology and Immunology, KU Leuven-University of Leuven, Leuven, Belgium; Department of Laboratory Medicine and National Reference Center for Medical Mycology, University Hospitals Leuven, Leuven, Belgium.
  • Marques A; Serviço de Imuno-Hemoterapia, Hospital de Braga, Braga, Portugal.
  • Lupiañez CB; Genomic Oncology Area, GENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
  • Mesquita I; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Gaifem J; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Barbosa AM; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Pinho Vaz C; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto, Porto, Portugal.
  • Branca R; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto, Porto, Portugal.
  • Campilho F; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto, Porto, Portugal.
  • Freitas F; Instituto Português do Sangue e Transplantação, IP, Porto, Portugal.
  • Ligeiro D; Instituto Português do Sangue e Transplantação, IP, Lisbon, Portugal.
  • Lass-Flörl C; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Löffler J; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Jurado M; Genomic Oncology Area, GENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
  • Saraiva M; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal; IBMC-Instituto de Biologia Molecular e Celular, University of Porto, Porto, Portugal.
  • Kurzai O; Septomics Research Centre, Friedrich Schiller University and Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany.
  • Rodrigues F; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Castro AG; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Silvestre R; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Sainz J; Genomic Oncology Area, GENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
  • Maertens JA; Department of Hematology, University Hospitals Leuven, Leuven, Belgium.
  • Torrado E; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Jacobsen ID; Research Group Microbial Immunology, Friedrich Schiller University and Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany.
  • Lacerda JF; Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Lisbon, Portugal; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Lisbon, Portugal.
  • Campos A; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto, Porto, Portugal.
  • Carvalho A; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's PT Government Associate Laboratory, Braga/Guimarães, Portugal. Electronic address: agostinhocarvalho@med.uminho.pt.
J Allergy Clin Immunol ; 140(3): 867-870.e9, 2017 09.
Article en En | MEDLINE | ID: mdl-28389392

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aspergilosis / Interleucina-10 / Predisposición Genética a la Enfermedad Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: J Allergy Clin Immunol Año: 2017 Tipo del documento: Article País de afiliación: Portugal

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aspergilosis / Interleucina-10 / Predisposición Genética a la Enfermedad Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: J Allergy Clin Immunol Año: 2017 Tipo del documento: Article País de afiliación: Portugal